For the Inventor, By the Inventor

Enter inventor name

Bothell, WA, United States of America

James R Piggott

USPTO Granted Patents = 14

CIPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 189(Granted Patents)

Company Filing History:

Zymogenetics, Inc.

Novo Nordisk A/s

Years Active: 1994-2001

Loading Chart...

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6268367 - Piperazine derivatives for treating bone deficit conditions (2001-07-31),

2. 5747059 - Atrophy of skin/mucous membrane (1998-05-05),

3. 5698521 - Native calcitonin mimetics (1997-12-16),

4. 5677334 - Method for inhibiting the stimulation of a glucagon-induced response (1997-10-14),

5. 5583143 - Methods for inhibiting calmodulin activity (1996-12-10),

6. 5552413 - Methods for inhibiting hyperproliferation of kerntinocytes (1996-09-03),

7. 5510459 - Glucagon antagonists (1996-04-23),

8. 5508304 - Glucagon antagonists and methods relating thereto (1996-04-16),

9. 5480903 - 3,4-diarylchromans for inhibiting calmodulin activity (1996-01-02),

10. 5464862 - Method for inhibiting bone loss using centchroman derivatives (1995-11-07),

11. 5451603 - 3,4-diarylchromans for treatment of dermatitis (1995-09-19),

12. 5416098 - Method for treating dermatitis and related conditions (1995-05-16),

13. 5408037 - Methods for detecting glucagon antagonists (1995-04-18),

14. 5280040 - Methods for reducing bone loss using centchroman derivatives (1994-01-18),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…